Tech Company Financing Transactions

NovoStent Funding Round

NovoStent, operating out of Mountain View, raised $10.8 million from Sanderling Ventures and private investors.

Transaction Overview

Company Name
Announced On
9/30/2008
Transaction Type
Venture Equity
Amount
$10,800,000
Round
Undisclosed
Investors

Sanderling Ventures (Timothy Mills)

Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Out of Business
Industry
Medical Devices & Instruments
Mailing Address
1400 Terra Bella Ave E
Mountain View, CA 94043
USA
Email Address
Overview
NovoStent Corporation is a medical device company that has developed a novel anchored helical stent technology to provide a wide range of vascular therapies.
Profile
NovoStent LinkedIn Company Profile
Social Media
NovoStent Company Twitter Account
Company News
NovoStent News
Facebook
NovoStent on Facebook
YouTube
NovoStent on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Rick Randall
  Rick Randall LinkedIn Profile  Rick Randall Twitter Account  Rick Randall News  Rick Randall on Facebook


 

 

Browse more venture capital transactions:

Prev: 9/30/2008: Satori Group venture capital transaction
Next: 9/30/2008: Acculynk venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on every notable VC transaction. All VC database entries reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary